Tag: Neutrophilia

Approximately 5.7% of hospitalized nonsurgical patients receiving steroids develop leukocytosis, with the degree often linked to the dosage. This highlights how certain medications increase leukocytes, or white blood cells, a condition known as drug-induced leukocytosis. It's a common side effect of many therapeutic drugs and often resolves once the medication is discontinued.

Within 48 hours of starting high-dose corticosteroid treatment, many patients experience a significant increase in their white blood cell (WBC) count, a phenomenon known as steroid-induced leukocytosis. This rapid and dose-dependent response is a predictable pharmacological effect, not a sign of infection, and understanding its timeline is critical for proper patient management.